Search results
What the Fed’s continued rate pause means for homebuyers and sellers
New Hampshire Union Leader· 5 days agoInflation is still running well above plan, and that means the Federal Reserve is keeping its finger...
The Federal Reserve’s latest dot plot, explained – and what it says about interest rates
Bankrate via Yahoo Finance· 6 days agoSay you’re wondering when to lock in a certificate of deposit (CD), and you want to snag a bank’s...
National average money market account rates for June 2024
Bankrate via Yahoo Finance· 5 days agoMore than 500 banks and credit unions are surveyed weekly to generate the national... these...
RenovoRx (NASDAQ:RNXT) Receives New Coverage from Analysts at Ascendiant Capital Markets
ETF DAILY NEWS· 16 hours agoAscendiant Capital Markets assumed coverage on shares of RenovoRx (NASDAQ:RNXT – Free Report) in a report issued on Monday morning, Benzinga reports. The firm issued a buy rating and a $8.00 ...
Take these 12 steps as the Federal Reserve keeps interest rates high
Bankrate via Yahoo Finance· 6 days agoYet, some forward-planning where possible can pay off when the Fed is on the verge of a turning...
5 Banking Mistakes to Avoid - NerdWallet
Nerdwallet· 6 days agoIf you have a checking account, you should also have a savings account. The ones that do generally offer much lower rates than the best free savings...
‘I have a chronic illness’: My husband and I are in our 30s, earn $120,000 and pay $1,500 in rent....
MarketWatch via Yahoo Finance· 6 days agoHistorically, that’s a pretty good rate. Real estate is a long-term investment, especially given...
How to manage retirement savings with interest rates remaining elevated
AOL· 3 days agoInterest rates will stay higher for longer in 2024. The Federal Reserve held interest rates at a 23-year high this week while curtailing its estimate of rate cuts this year ...
AMETEK, Inc. (NYSE:AME) Given Average Recommendation of “Moderate Buy” by Analysts
ETF DAILY NEWS· 4 days agoShares of AMETEK, Inc. (NYSE:AME – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the eleven analysts that are covering the company, Marketbeat reports. Three ...
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory...
Morningstar· 4 days agoPfizer Inc. (NYSE: PFE) today announced detailed overall survival (OS) results from the Phase 2 MagnetisMM-3 study of ELREXFIO™ (elranatamab-bcmm) in patients with heavily pretreated relapsed ...